Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Dec 6;19(1):269.
doi: 10.1186/s13075-017-1475-x.

Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren's syndrome

Maëlle Le Goff  1 , Divi Cornec  2   3 , Sandrine Jousse-Joulin  1   4 , Dewi Guellec  1 , Sebastian Costa  4   5 , Thierry Marhadour  1 , Rozenn Le Berre  6 , Steeve Genestet  7 , Béatrice Cochener  8 , Sylvie Boisrame-Gastrin  9 , Yves Renaudineau  4   10 , Jacques-Olivier Pers  4   9 , Alain Saraux  1   4 , Valérie Devauchelle-Pensec  1   4
Affiliations
Comparative Study

Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren's syndrome

Maëlle Le Goff et al. Arthritis Res Ther. .

Abstract

Background: The objective was to evaluate concordance between 2002 American-European Consensus Group (AECG) and 2016 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) classification criteria for primary Sjögren's syndrome (pSS) and to assess how salivary gland ultrasonography (SGUS) might improve the classification of patients.

Methods: Patients with suspected pSS underwent a standardised evaluation, including SGUS, at inclusion into the single-centre Brittany DIApSS cohort. Agreement between the two criteria sets was assessed using Cohen's κ coefficient. Characteristics of discordantly categorised patients were detailed.

Results: We prospectively included 290 patients between 2006 and 2016, among whom 125 (43%) met ACR/EULAR criteria and 114 (39%) also met AECG criteria; thus, 11 (4%) patients fulfilled only ACR/EULAR, no patients AECG only, and 165 (57%) patients neither criteria set. Concordance was excellent (κ = 0.92). Compared to patients fulfilling both criteria sets, the 11 patients fulfilling only ACR/EULAR criteria had similar age and symptom duration but lower frequencies of xerophthalmia and xerostomia (p < 0.01 for each) and salivary gland dysfunction (p < 0.01); most had systemic involvement (91%), including three (27%) with no sicca symptoms; 91% had abnormal salivary gland biopsy and 46% anti-Sjögren's-syndrome-related antigen A (anti-SSA); 64% were diagnosed with pSS by the physician. SGUS was abnormal in 12% of the 165 patients fulfilling no criteria set. Including SGUS among the ACR/EULAR criteria increased sensitivity from 87.4% to 91.1% when physician diagnosis was the reference standard.

Conclusions: Agreement between AECG and ACR/EULAR criteria sets is excellent. ACR/EULAR criteria are slightly more sensitive and classified some patients without sicca symptoms as having pSS. Including SGUS in the ACR/EULAR criteria may further improve their sensitivity.

Keywords: Classification criteria; Diagnosis; Primary; Sjögren’s syndrome; Ultrasonography.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

All participants gave written informed consent, and the study was approved by the Brest University Hospital institutional review board.

Consent for publication

No personal and identifiable data are included in the manuscript.

Competing interests

The authors have no conflicts of interest to declare concerning this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Brito-Zerón P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. Sjögren syndrome. Nat Rev Dis Primer. 2016;2:16047. doi: 10.1038/nrdp.2016.47. - DOI - PubMed
    1. Cornec D, Chiche L. Is primary Sjögren’s syndrome an orphan disease? A critical appraisal of prevalence studies in Europe. Ann Rheum Dis. 2015;74:e25. doi: 10.1136/annrheumdis-2014-206860. - DOI - PubMed
    1. Maciel G, Crowson CS, Matteson EL, Cornec D. Prevalence of primary Sjögren’s syndrome in a population-based cohort in the United States. Arthritis Care Res (Hoboken) 2017;69(10):1612–1616. doi: 10.1002/acr.23173. - DOI - PMC - PubMed
    1. Brito-Zerón P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren’s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Ann Rheum Dis. 2017;76:1042–50. doi: 10.1136/annrheumdis-2016-209952. - DOI - PubMed
    1. Maciel G, Crowson CS, Matteson EL, Cornec D. Incidence and mortality of physician-diagnosed primary Sjögren syndrome: time trends over a 40-year period in a population-based US cohort. Mayo Clin Proc. 2017;92(5):734–43. doi: 10.1016/j.mayocp.2017.01.020. - DOI - PMC - PubMed

Publication types